Manejo y tratamiento en pacientes con enfermedad por coronavirus 2019 (COVID-19) y sus implicaciones endocrinológicas

Abstract

There is currently no specific treatment for patients with coronavirus disease 2019 (COVID-19). Confirmed cases of severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2) should be treated with effective conditions of isolation and protection, in addition to infection control; Critical cases should be admitted to the intensive care unit as soon as possible. Those subjects with chronic diseases, such as diabetes, obesity,and hypertension, are identified as groups with a higher risk of contagion and severe COVID-19. There are a significant number of pharmacological targets, such as virus life cycle, viral routes of entry, and immune regulation, however, there is currently no evidence from randomized clinical trials that any potential therapy improves outcomes in hospitalized patients with COVID.-19, there are no data to support any prophylactic therapy, much less that they are harmless. The disease pandemic caused by the new SARSCoV-2 presents an unprecedented challenge for medical personnel, including the endocrinologist, as they face a new nosological and therapeutic challenge.